Key facts
- Exero Medical’s last known valuation is $13.0M (Feb 2025).
- It has raised $14.0M; the latest was Later Stage VC ($12.7M) in Feb 2025.
- Notable investors include Innovation Authority, Tech Council Ventures, Consensus Business Group, Intellectual Ventures, ARC Innovation Center — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Exero Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Exero Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Exero Medical
Developer of a biodegradable wireless sensor designed for early detection of anastomotic leaks following gastrointestinal surgery. The company's device provides patient recovery, the generation of new real-time data, and shorter hospitalization, enabling medical professionals to monitor the condition of the anastomosis area and take preventive actions before the patient's condition deteriorates.
- Sector
- Healthcare
- HQ
- Or Yehuda, Israel
- Founded
- 2018
- Employees
- 9
- Website
- exeromedical.com/
- Ownership
- Privately Held (backing)
Exero Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Exero Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Exero Medical in its N-PORT filings yet. We sweep new filings monthly.